PharmaShots | Incisive News in 3 Shots

Subscribe Now

CAR T cell Therapy

$BMS' Abecma (idecabtagene vicleucel) Receives the Health Canada's Approval as the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma$

BMS' Abecma (idecabtagene vicleucel) Receives the Health Canada's Approval as the First Anti-BCMA CAR T Cell Therapy for Relapsed...

June 1, 2021

Precision BioSciences Receives the US FDA's Fast Track Designation for PBCAR0191 to Treat Advanced B-cell Precursor Acute Lymphoblastic Leukemia

Precision BioSciences Receives the US FDA's Fast Track Designation for PBCAR0191 to Treat Advanced B-cell Precursor Acute Lymphobl...

August 20, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us